Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (Q2788513): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Set OpenAlex properties. |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Property / author | |||
| Property / author: Yuri Kogan / rank | |||
| Property / author | |||
| Property / author: Benjamin Ribba / rank | |||
| Property / author | |||
| Property / author: Vladimir Vainstein / rank | |||
| Property / author | |||
| Property / author: Zvia Agur / rank | |||
| Property / author | |||
| Property / author: Yuri Kogan / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Benjamin Ribba / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Vladimir Vainstein / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Zvia Agur / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1051/mmnp:2007003 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2118773579 / rank | |||
Normal rank | |||
Revision as of 00:27, 20 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement |
scientific article |
Statements
Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (English)
0 references
19 February 2016
0 references
mathematical model
0 references
vascular tumour
0 references
avascular tumour
0 references
heterogeneity
0 references
chemotherapy
0 references
non-Hodgkin lymphoma
0 references
CHOP
0 references
doxorubicin
0 references
hybrid cellular automata
0 references
